Laurion Capital Management
GOSS icon

Laurion Capital Management’s Gossamer Bio GOSS Stock Holding History

Laurion Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,797
Closed -$1.65M – 325
2025
Q2 		$1.65M Sell
16,797
-2,596
-13% -$227K 0.03% 173
2025
Q1 		$1.71M Buy
19,393
+793
+4% +$73.3K 0.04% 153
2024
Q4 		$1.35M Hold
18,600
– – 0.02% 198
2024
Q3 		$1.47M Sell
18,600
-12,196
-40% -$939K 0.02% 172
2024
Q2 		$2.22M Buy
30,796
+2,035
+7% +$122K 0.03% 218
2024
Q1 		$2.72M Buy
+28,761
New +$2.53M 0.02% 316
2023
Q2 		– Sell
-712
Closed -$71.8K – 642
2023
Q1 		$71.8K Buy
+712
New +$109K ﹤0.01% 406
2019
Q2 		– Sell
-313
Closed -$542K – 997
2019
Q1 		$542K Buy
+313
New +$522K 0.01% 620

Other funds holding GOSS

NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Octagon Capital Advisors
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Arch Venture Management
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Samsara BioCapital
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Palo Alto Investors
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Laurion Capital Management's GOSS Position: Q3 2025 in Review

Laurion Capital Management sold out of Gossamer Bio (GOSS) in Q3 2025, closing a stake of 16,797 shares — an estimated $1.65M sold.

Laurion Capital Management first reported a position in GOSS in Q1 2019 and held it in 8 quarters. The position peaked at $2.72M in Q1 2024. 163 funds tracked by Wall St. Rank hold GOSS as of Q3 2025.

  • Laurion Capital Management reported no remaining Gossamer Bio position as of Q3 2025 after selling out during the quarter.
  • Laurion Capital Management sold 16,797 Gossamer Bio shares in Q3 2025, an estimated $1.65M.
  • Laurion Capital Management first reported a position in Gossamer Bio in Q1 2019 and held it in 8 quarters.
  • Laurion Capital Management's Gossamer Bio position peaked at $2.72M in Q1 2024.
  • 163 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2025.

Based on Laurion Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.